Internal Medicine, Addiction Medicine · Beverly Hills, CA
NPI
1083761670
Since 2007
Specialty
Internal Medicine, Addiction Medicine
Code 207RA0401X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8484 Wilshire Blvd, Suite 200
Beverly Hills, CA, 90211
Phone (310) 360-7690
Groups this clinician bills Medicare through
Medicare paid, 2024
$282K
9,458 services
Medicare patients, 2024
96
Average age 69
Drug cost, 2024
$7.4M
7,186 prescriptions
Company payments, 2025
$5,231
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark R Honzel was code J2405 (injection, ondansetron hydrochloride, per 1 mg), 892 times for 13 patients. In total Mark R Honzel billed 9,458 services in 40 codes, and Medicare paid $282K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 892 | 13 | $0.07 | $66.02 |
| 99442 Telephone Services | Office | 343 | 75 | $68.46 | $23K |
| 96366 Intravenous Infusion, Hydration | Office | 254 | 12 | $18.11 | $4,600 |
| 99213 Office E&M - Established | Office | 225 | 70 | $72.04 | $16K |
| 99441 Telephone Services | Office | 127 | 48 | $44.39 | $5,637 |
| 96375 Injection Administration | Office | 117 | 13 | $13.77 | $1,611 |
| 36415 Venipuncture Blood Collection | Office | 112 | 63 | $8.65 | $969 |
| 96365 Intravenous Infusion, Hydration | Office | 112 | 13 | $56.47 | $6,324 |
| 36410 Vascular | Office | 108 | 13 | $14.04 | $1,516 |
| 96374 Injection Administration | Office | 103 | 13 | $32.82 | $3,381 |
| 99214 Office E&M - Established | Office | 99 | 54 | $103.22 | $10K |
| 99443 Telephone Services | Office | 72 | 33 | $100.50 | $7,236 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 61 | 11 | $0.65 | $39.58 |
| 99212 Office E&M - Established | Office | 33 | 23 | $46.37 | $1,530 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $35.02 | $560 |
By year: 2022 $310K for 10,381 services; 2023 $303K for 9,231 services; 2024 $282K for 9,458 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 112 | 63 | $8.65 | $969 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark R Honzel prescribed most often to Medicare patients was Tamsulosin Hcl, with 220 prescriptions and refills. In total Mark R Honzel wrote 7,186 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 220 | 286 | 28 | $1,637 |
| Atorvastatin Calcium Generic | 195 | 296 | 32 | $685 |
| Oxycodone Hcl Generic | 189 | 193 | 19 | $4,396 |
| Serostim Somatropin | 182 | 182 | 14 | $3.6M |
| Gabapentin Generic | 176 | 206 | 29 | $2,173 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 169 | 169 | 15 | $663K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 163 | 163 | 19 | $4,751 |
| Ibuprofen Generic | 158 | 172 | 28 | $1,505 |
| Pantoprazole Sodium Generic | 147 | 225 | 23 | $1,260 |
| Losartan Potassium Generic | 138 | 196 | 23 | $594 |
| Amlodipine Besylate Generic | 127 | 173 | 21 | $277 |
| Metformin Hcl Generic | 125 | 191 | 23 | $598 |
| Testosterone Cypionate Generic | 118 | 125 | 16 | $5,071 |
| Escitalopram Oxalate Generic | 114 | 144 | 12 | $499 |
| Buprenorphine Hcl Generic | 104 | 104 | 12 | $4,051 |
Brand drugs: 1,410 claims; generic drugs: 5,750 claims; opioid claims: 608.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark R Honzel $5,231 ($5,231 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $689.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $689 |
| Vanda Pharmaceuticals Inc. VNDA | 26 | $589 |
| Axsome Therapeutics, Inc. AXSM | 27 | $553 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 16 | $460 |
| ViiV Healthcare Company GSK | 15 | $421 |
| Indivior Inc. INDV | 12 | $330 |
| Lundbeck LLC | 14 | $326 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 15 | $308 |
| Gilead Sciences, Inc. GILD | 8 | $221 |
| Alkermes, Inc. ALKS | 7 | $219 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.